You can read our Premium News Service in full if you have an Annual Subscription to the OTCToolbox website. You can read Basic News stories free of charge.
7 May 2021
Recordati plans to increase sales of its Procto-Glyvenol haemorrhoid treatment by more than a third by 2023 as part of a three-year plan which also includes developing new probiotic food supplements and acquisitions of OTC brands.
5 May 2021
Sanofi Consumer Healthcare is relaunching its Zantac brand in the US with famotidine as the active ingredient instead of ranitidine. The news comes as the business reported worldwide sales down by 7.3% at constant exchange rates in the first quarter of 2021.
3 May 2021
Futura Medical’s MED3000 topical gel for erectile dysfunction has now been certified as a Class IIb medical device in the European Union. The company told OTCToolbox it was "in discussions with a number of parties" about marketing and distribution rights.